Outlook Therapeutics EV/EBITDA Ratio 2011-2026 | OTLK

Annual EV/EBITDA Ratio Outlook Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-3.04	-1.36	-1.17	-1.95	-1.42	-1.56	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-1.17	-3.04	-1.75

EV/EBITDA Ratio of other stocks in the Biotechnology industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-0.591	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	1.84	-	1052.0 %	$ 415 M	USA
Veracyte VCYT	-43.4	$ 30.92	-5.73 %	$ 2.43 B	USA
Aeterna Zentaris AEZS	4.4	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-1.85	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-4.27	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	-45.5	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	-1.13	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	-4.64	-	-	$ 3.67 B	USA
I-Mab IMAB	595	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	10.7	-	-	$ 40.3 B	USA
Genfit SA GNFT	4.22 K	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	-3.38	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	-0.0369	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	-1.56	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	0.796	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.42	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	-9.01	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	0.546	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	0.871	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	0.785	-	-	$ 7.46 M	Israel
Atreca BCEL	-2.76	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	0.777	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	-0.805	-	-	$ 546 M	USA
Acasti Pharma ACST	1.8	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	14	-	-	-	Russia
Avid Bioservices CDMO	109	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	-1.32	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-3.39	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-82.4	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	-10.9	$ 12.67	-9.24 %	$ 1.92 B	USA
BeiGene, Ltd. BGNE	-208	-	0.49 %	$ 251 B	Cayman-islands
Alnylam Pharmaceuticals ALNY	-31.5	$ 321.51	-2.03 %	$ 42.1 B	USA
BioDelivery Sciences International BDSI	8	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	-6.7	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-0.721	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	-1	$ 1.09	-	$ 22.4 M	Israel
Enochian Biosciences ENOB	-7.22	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	-7.74	-	-	$ 867 M	Germany
Equillium EQ	-1.46	$ 1.91	-7.28 %	$ 109 M	USA
Amphastar Pharmaceuticals AMPH	17.3	$ 19.46	-0.36 %	$ 910 M	USA
Amarin Corporation plc AMRN	123	$ 14.23	-2.97 %	$ 5.91 B	Irlanda
Bellerophon Therapeutics BLPH	0.0235	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	13.1	$ 45.99	-3.28 %	$ 4.14 B	Schweiz
Arbutus Biopharma Corporation ABUS	-3.41	$ 4.33	-2.81 %	$ 830 M	Canada
Allakos ALLK	-1.56	-	-	$ 28.6 M	USA
Brickell Biotech BBI	0.668	-	-5.38 %	$ 6.06 M	USA
Freeline Therapeutics Holdings plc FRLN	0.438	-	-	$ 384 M	Britain
Allena Pharmaceuticals ALNA	0.298	-	3.16 %	$ 1.9 M	USA